🇺🇸 Progesterone in United States

FDA authorised Progesterone on 1 November 1974

Marketing authorisations

FDA — authorised 1 November 1974

  • Application: NDA009238
  • Marketing authorisation holder: LILLY
  • Local brand name: PROGESTERONE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 11 May 1978

  • Application: NDA017362
  • Marketing authorisation holder: ACTAVIS LABS UT INC
  • Local brand name: PROGESTERONE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 22 June 2009

  • Application: ANDA090845
  • Marketing authorisation holder: AM REGENT
  • Local brand name: PROGESTERONE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 29 February 2012

  • Application: ANDA202121
  • Marketing authorisation holder: TEVA PHARMS
  • Local brand name: PROGESTERONE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 16 August 2013

  • Application: ANDA200900
  • Marketing authorisation holder: BIONPHARMA
  • Local brand name: PROGESTERONE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 20 October 2017

  • Application: ANDA205229
  • Marketing authorisation holder: XIROMED
  • Local brand name: PROGESTERONE
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

FDA — authorised 5 January 2022

  • Application: ANDA215634
  • Marketing authorisation holder: XIROMED
  • Local brand name: PROGESTERONE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 21 November 2023

  • Application: ANDA217707
  • Marketing authorisation holder: ACCORD HLTHCARE
  • Local brand name: PROGESTERONE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 19 September 2025

  • Application: ANDA218391
  • Marketing authorisation holder: XIROMED
  • Local brand name: PROGESTERONE
  • Indication: INSERT — VAGINAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Progesterone in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Progesterone approved in United States?

Yes. FDA authorised it on 1 November 1974; FDA authorised it on 11 May 1978; FDA authorised it on 22 June 2009.

Who is the marketing authorisation holder for Progesterone in United States?

LILLY holds the US marketing authorisation.